Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349

Inclusion Criteria: * Must be healthy males or non-pregnant females * Have a Body Mass Index (BMI) between 18 and 32 (both inclusive), calculated as weight in kg / height in m2 * Have no significant diseases or clinically significant abnormal findings during screening, medical history, physical examination, laboratory evaluations and ECG recordings. * Should test negative for drugs of abuse and urine alcohol test. Exclusion Criteria: * Known hypersensitivity or idiosyncratic reaction to quinolones or any other related drugs. * Any history or evidence of disease or condition which might compromise the haemopoietic, renal, hepatic, endocrine, pulmonary, central nervous, cardiovascular, immunological, dermatological, gastrointestinal or any other body system.